Allan Oberman became President and Chief Executive Officer of Teva Americas Generics in November 2012, after serving as the head of Teva’s North America Generics division. From 2010 to 2012, Mr. Oberman served as President of Teva EMIA, where he had responsibility for Eastern Europe, Middle East, Israel and Africa.. From 2008 to 2010, Mr.. Oberman served as the Chief Operating Officer of the Teva International Group. From 2000 to 2008, Mr. Oberman served as the President and CEO of Novopharm Ltd., which is now Teva Canada.. Prior to joining Teva, from 1996 to 2000, Mr. Oberman was the President of Best Foods Canada Inc.. Mr. Oberman holds a MBA from the Schulich School of Business, York University and a BA from the University of Western Ontario.
